Keyphrases
Glucagon-like
100%
Glucagon Secretion
100%
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Endogenous Glucose Production
33%
Plasma Glucose
33%
Glucagon Suppression
33%
Whole-body
22%
Glucagon
22%
Insulinotropic Effects
22%
Hyperglucagonemia
22%
Non-diabetic
22%
Suppression Effect
11%
Lipolysis
11%
Respiratory Quotient
11%
Postprandial Glucose
11%
Homeostasis Model Assessment
11%
Stable Isotopes
11%
Lipolysis Rate
11%
Placebo
11%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
11%
Indirect Calorimetry
11%
Fasting Plasma Glucose
11%
Glycaemia
11%
Insulin Resistance
11%
Intravenous Infusion
11%
Plasma Parameters
11%
Liver Biopsy
11%
Medicine and Dentistry
Nonalcoholic Fatty Liver
100%
Glucagon Like Peptide 1
100%
Glucagon Release
100%
Glucagon
55%
Gluconeogenesis
33%
Diabetes Mellitus
22%
Hyperglucagonemia
22%
Insulin Like Activity
22%
Lipolysis
22%
Homeostatic Model Assessment
11%
Infusion
11%
Stable Isotope
11%
Indirect Calorimetry
11%
Placebo
11%
Intravenous Drug Administration
11%
Respiratory Quotient
11%
Liver Biopsy
11%
Biochemistry, Genetics and Molecular Biology
Glucagon Release
100%
Glucagon-Like Peptide-1
100%
Glucagon
55%
Gluconeogenesis
33%
Glucose Blood Level
33%
Insulin Like Activity
22%
Blood Plasma
22%
Glucose Level
22%
Lipolysis
22%
Calorimetry
11%
Homeostasis
11%
Respiratory Quotient
11%
Blood Level
11%
Neuroscience
Glucagon
100%
Glucagon-Like Peptide-1
100%
Blood Plasma
55%
Gluconeogenesis
33%
Lipolysis
22%
Diabetes Mellitus
22%
Respiratory Quotient
11%
Placebo
11%
Calorimetry
11%
Agricultural and Biological Sciences
Glucagon
100%
Glucagon-Like Peptide-1
100%
Blood Plasma
55%
Gluconeogenesis
33%
Lipolysis
22%
Calorimetry
11%
Placebo
11%
Respiratory Quotient
11%
Homeostasis
11%